BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10690046)

  • 1. Amifostine.
    Viele C
    Clin J Oncol Nurs; 1999 Jul; 3(3):128, 131. PubMed ID: 10690046
    [No Abstract]   [Full Text] [Related]  

  • 2. Administration of the cytoprotectant amifostine.
    Lindemann K
    Clin J Oncol Nurs; 1998 Jul; 2(3):101-4. PubMed ID: 10232150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Amifostine as a supporting treatment during cancer therapy].
    Jantunen E; Puistola U
    Duodecim; 1999; 115(11):1223-7. PubMed ID: 11877841
    [No Abstract]   [Full Text] [Related]  

  • 4. Amifostine protects against cisplatin-induced nephrotoxicity in a child with medulloblastoma.
    Hayek M; Srinivasan A
    Pediatr Hematol Oncol; 2003; 20(3):253-6. PubMed ID: 12637222
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Sodium thiosulfate in cisplatin overdose by Erdlenbruch B et al., Med Pediatr Oncol 2002;38:349-352.
    Bleyer A; Alberts DS
    Med Pediatr Oncol; 2003 Jun; 40(6):413; author reply 414. PubMed ID: 12692822
    [No Abstract]   [Full Text] [Related]  

  • 6. Cisplatin nephrotoxicity affects magnesium and calcium metabolism.
    Goren MP
    Med Pediatr Oncol; 2003 Sep; 41(3):186-9. PubMed ID: 12868117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amifostine in reducing cisplatin toxicity.
    Markman M
    Semin Oncol; 1998 Oct; 25(5):522-4. PubMed ID: 9783591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments and emerging options: the role of amifostine as a broad-spectrum cytoprotective agent.
    Capizzi RL
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):1-2. PubMed ID: 10348254
    [No Abstract]   [Full Text] [Related]  

  • 9. Radioprotectants: adding quality of life to survivorship?
    Dest VM
    Semin Oncol Nurs; 2006 Nov; 22(4):249-56. PubMed ID: 17095401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of normal tissue from the cytotoxic effects of chemotherapy and radiation by amifostine: clinical experiences.
    Capizzi RL; Oster W
    Eur J Cancer; 1995; 31A Suppl 1():S8-13. PubMed ID: 7577096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of normal tissues from the cytotoxic effects of chemotherapy and radiation by amifostine (WR-2721): preclinical aspects.
    Peters GJ; van der Vijgh WJ
    Eur J Cancer; 1995; 31A Suppl 1():S1-7. PubMed ID: 7577093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential for use of amifostine in cervical cancer.
    Small W
    Semin Oncol; 2002 Dec; 29(6 Suppl 19):34-7. PubMed ID: 12577241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology.
    Schuchter LM; Hensley ML; Meropol NJ; Winer EP;
    J Clin Oncol; 2002 Jun; 20(12):2895-903. PubMed ID: 12065567
    [No Abstract]   [Full Text] [Related]  

  • 14. [Amifostine otoprotection to cisplatin ototoxicity: a guinea pig study using otoacoustic emission distortion products (DPOEA) and scanning electron microscopy].
    Hyppolito MA; de Oliveira AA; Lessa RM; Rossato M
    Braz J Otorhinolaryngol; 2005; 71(3):268-73. PubMed ID: 16446928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of the efficacy of amifostine in the prevention of cisplatin ototoxicity.
    Duval M; Daniel SJ
    J Otolaryngol Head Neck Surg; 2012 Oct; 41(5):309-15. PubMed ID: 23092832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of amifostine in the treatment of head and neck cancer with cisplatin-radiotherapy.
    Marcu LG
    Eur J Cancer Care (Engl); 2009 Mar; 18(2):116-23. PubMed ID: 19267726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic study of paclitaxel administered with or without the cytoprotective agent amifostine, and given as a single agent or in combination with epirubicin and cisplatin in patients with advanced solid tumors.
    Van den Brande J; Nannan Panday VR; Hoekman K; Rosing H; Huijskes RV; Verheijen RH; Beijnen JH; Vermorken JB
    Am J Clin Oncol; 2001 Aug; 24(4):401-3. PubMed ID: 11474273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amifostine: a tonic or toxin to myeloid progenitors.
    List AF; Gerner EW
    Leuk Res; 2000 Dec; 24(12):1009-11. PubMed ID: 11077114
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cytoprotective effect of Amifostine in the combined chemotherapy of advanced ovarian carcinoma].
    Nagy P; Kádasi L
    Orv Hetil; 2000 Sep; 141(37):2027-30. PubMed ID: 11037611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of cisplatin-vinblastine plus amifostine in patients with locally advanced or metastatic non-small cell lung cancer.
    Thongprasert S; Chewaskulyong B
    J Med Assoc Thai; 2004 Oct; 87(10):1162-7. PubMed ID: 15560691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.